CRT currently provides development and commercialisation services to many internationally renowned cancer research funding bodies, research establishments and cancer charities. The organisation has extended the traditional activities of technology transfer to encompass development funding and applied development capabilities. In this respect, CRT is distinctive amongst commercialisation companies in having its own Discovery Laboratories, with core competences in molecular and cellular biology, drug discovery, early pharmacology and medicinal chemistry. Such activities add value to a scientist's initial invention and in so doing create robust licensing opportunities. In addition to the unique development and commercialisation services, CRT's worldwide network of research partners also enables it to identify and bring together the widest possible complementary research to form attractive opportunities for commercial partners.

CRT's exclusive focus on oncology gives it an unrivalled array of expertise and commercial contacts. Companies which licence technologies, or collaborate with CRT, know that the opportunities have been rigorously screened, selected and developed from the highest quality international cancer research.

CRT offers research establishments an unparalleled development and commercialisation services for their oncology-focused intellectual property:

• Over 20 years' successful experience of choosing the optimal development pathway and commercialisation route for new cancer discoveries and inventions;
• In depth understanding of the needs of academic and charitable research institutions;
• Willingness to engage in flexible working and financial arrangements to satisfy the individual priorities of the institute and its scientists;
• Ability to undertake rapid applied development to add value to new inventions through CRT's Discovery Laboratories and development funding;
• In-house professional, legal and business development resources;
• Strong business development credibility amongst a global network of oncology-focused biotechnology and pharmaceutical companies.

Please contact us if you would like to discuss the services CRT can offer your research establishment.